During the past decade, The Center for Rheumatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 12 clinical trials were completed, i.e. on average, 240% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Center for Rheumatology" #1 sponsor was "Pfizer" with 5 trials, followed by "MediQuest Therapeutics" with 4 trials sponsored, "Actelion" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Rheumatology" #1 collaborator was "Biogen" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Oregon Health and Science University" with 1 trials as a collaborator and "University of Alabama at Birmingham" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "The Center for Rheumatology" are "Rheumatoid Arthritis" (12 trials), "Arthritis, Rheumatoid" (5 trials), "Raynaud's Disease" (5 trials), "Systemic Sclerosis" (3 trials) and "Arthritis" (2 trials). Many other conditions were trialed in "The Center for Rheumatology" in a lesser frequency.

Most popular intervention types in "The Center for Rheumatology" are "Drug" (27 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Belimumab 1 mg/kg" (2 trials), "Belimumab 10 mg/kg" (2 trials), "Belimumab 4 mg/kg" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Center for Rheumatology" are 33 trials for "All" genders.

Currently, there are NaN active trials in "The Center for Rheumatology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in The Center for Rheumatology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in The Center for Rheumatology, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".